Zinc concentration in patients with iron overload receiving oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one or desferrioxamine.

AIMS--To determine the changes in serum zinc concentration and the extent of urinary zinc excretion in patients with iron overload receiving the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) or desferrioxamine (DFX), and to correlate these results with blood glucose concentration. METHOD...

Cijeli opis

Bibliografski detalji

Izdano u:	J Clin Pathol
Glavni autori:	al-Refaie, F N, Wonke, B, Wickens, D G, Aydinok, Y, Fielding, A, Hoffbrand, A V
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 1994
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC502110/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8089225/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.47.7.657
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!